Table 1.
Patient characteristics.
| Characteristic | Value |
|---|---|
| Age (years) | |
| Median | 49 |
| Range | 26–66 |
| Menopausal status, n (%) | |
| Premenopausal | 33 (59%) |
| Postmenopausal | 23 (41%) |
| AJCC stage, n (%) | |
| Stage 2 | 12 (21%) |
| Stage 3 | 44 (79%) |
| Estrogen receptor status, n (%) | |
| Positive | 25 (45%) |
| Negative | 30 (53%) |
| No data | 1 (2%) |
| Progesterone receptor status, n (%) | |
| Positive | 32 (57%) |
| Negative | 23 (41%) |
| No data | 1 (2%) |
| HER2/neu status, n (%) | |
| Positive | 21 (37%) |
| Negative | 34 (61%) |
| No data | 1 (2%) |
| Histology, n (%) | |
| Invasive ductal carcinoma | 54 (96%) |
| Invasive lobular carcinoma | 1 (2%) |
| Mucinous carcinoma | 1 (2%) |
AJCC American Joint Committee on Cancer, HER2 human epidermal growth factor receptor-2.